Clinical Trials Browser

Choriocarcinoma × Methotrexate × Clear all

NCT04562558 2025-08-11

Biweekly Actinomycin-D Treatment or Multi-day Methotrexate Protocol in Low-risk Gestational Trophoblastic Neoplasia

Phase NA Active not recruiting

Hydatidiform Mole, Invasive, Choriocarcinoma, Gestational Trophoblastic Disease

NCT01535053 2022-08-12

Dactinomycin or Methotrexate in Treating Patients With Low-Risk Gestational Trophoblastic Neoplasia

Phase 3 Completed

57 enrolled 12 charts

Choriocarcinoma, Hydatidiform Mole